$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Transdermal therapeutic systems for the administration of naloxone, naltrexone and nalbuphine 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-009/00
출원번호 US-0659122 (1984-10-09)
발명자 / 주소
  • Chen Yu-Ling (Cupertino CA) Chun Leslie L. (Palo Alto CA) Enscore David J. (Sunnyvale CA)
출원인 / 주소
  • ALZA Corporation (Palo Alto CA 02)
인용정보 피인용 횟수 : 171  인용 특허 : 6

초록

A method for transdermal delivery of naloxone, naltrexone and nalbuphine base through intact skin is described. Preferred embodiments of transdermal therapeutic systems for delivering these drugs and polyethylene glycol monolaurate employ an ethylene vinylacetate matrix containing drug base at a con

대표청구항

The medical device of claim 25, wherein said permeation enhancer reservoir is combined with said material reservoir.

이 특허에 인용된 특허 (6)

  1. LaHann Thomas R. (Cleves OH) Buckwalter Brian L. (Yardley PA), Compositions and methods useful for producing analgesia.
  2. Leeper Harold M. (Mountain View CA), Elastomeric active agent delivery system and method of use.
  3. Hussain Anwar A. (Lexington KY), Method of administering narcotic antagonists and analgesics and novel dosage forms containing same.
  4. Olofson Roy A. (State College PA) Pepe Joseph P. (Rochester NY), N-dealkylation of N-alkyl-14-hydroxymorphinans and derivatives thereof.
  5. Campbell Patricia S. (Palo Alto CA) Chandrasekaran Santosh K. (Palo Alto CA), Percutaneous absorption enhancer dispenser for use in coadministering drug and percutaneous absorption enhancer.
  6. Chandrasekaran Santosh K. (Palo Alto CA) Darda Siegfried (Ingelheim am Rhein CA DEX) Michaels Alan S. (Atherton CA) Cleary Gary W. (Palo Alto CA), Therapeutic system for administering clonidine transdermally.

이 특허를 인용한 특허 (171)

  1. Matthews, Frank; Boehm, Garth; Tang, Lijuan; Liang, Alfred, Abuse-deterrent multi-layer pharmaceutical composition comprising an opioid antagonist and an opioid agonist.
  2. Matthews, Frank; Boehm, Garth; Tang, Lijuan; Liang, Alfred, Abuse-deterrent multi-layer pharmaceutical composition comprising an opioid antagonist and an opioid agonist.
  3. Caruso, Frank S.; Kao, Huai-Hung, Abuse-resistant controlled-release opioid dosage form.
  4. Caruso, Frank S.; Kao, Huai-Hung, Abuse-resistant controlled-release opioid dosage form.
  5. Caruso, Frank S.; Kao, Huai-Hung, Abuse-resistant controlled-release opioid dosage form.
  6. Caruso, Frank S.; Kao, Huai-Hung, Abuse-resistant controlled-release opioid dosage form.
  7. Caruso, Frank S.; Kao, Huai-Hung, Abuse-resistant controlled-release opioid dosage form.
  8. Caruso, Frank S.; Kao, Huai-Hung, Abuse-resistant controlled-release opioid dosage form.
  9. Caruso, Frank S.; Kao, Huai-Hung, Abuse-resistant controlled-release opioid dosage form.
  10. Caruso, Frank S.; Kao, Huai-Hung, Abuse-resistant controlled-release opioid dosage form.
  11. Caruso, Frank S.; Kao, Huai-Hung, Abuse-resistant controlled-release opioid dosage form.
  12. Caruso, Frank S.; Kao, Huai-Hung, Abuse-resistant controlled-release opioid dosage form.
  13. Caruso, Frank S.; Kao, Huai-Hung, Abuse-resistant controlled-release opioid dosage form.
  14. Mehta, Atul M., Abuse-resistant oral dosage forms and method of use thereof.
  15. Mehta, Atul M., Abuse-resistant oral dosage forms and method of use thereof.
  16. Mehta, Atul M., Abuse-resistant oral dosage forms and method of use thereof.
  17. Von Coburg, Yvonne; Reimer, Karen; Oksche, Alexander; Holzer, Peter, Combination of oxycodone and naloxone for use in treating pain in patients suffering from pain and a disease resulting in intestinal dysbiosis and/or increasing the risk for intestinal bacterial translocation.
  18. Bozik, Michael E.; Petzinger, Jr., Thomas; Mather, James L.; Archibald, Donald, Compositions and methods for treating amyotrophic lateral sclerosis in responders.
  19. Bozik, Michael E.; Petzinger, Jr., Thomas; Mather, James L.; Archibald, Donald, Compositions and methods for treating amyotrophic lateral sclerosis in responders.
  20. Bozik, Michael E.; Dworetzky, Steven, Compositions and methods for treating chronic urticaria.
  21. Bozik, Michael E; Dworetzky, Steven, Compositions and methods for treating chronic urticaria.
  22. Bozik, Michael E.; Hebrank, Gregory; Farwell, Wildon; Petzinger, Jr., Thomas; Dworetzky, Steven, Compositions and methods for treating conditions related to increased eosinophils.
  23. Bozik, Michael E.; Dworetzky, Steven, Compositions and methods for treating plasma cell disorders and B-cell prolymphocytic disorders.
  24. Bozik, Michael E.; Dworetzky, Steven, Compositions and methods for treating plasma cell disorders and B-cell prolymphocytic disorders.
  25. Bozik, Michael E.; Gribkoff, Valentin; Petzinger, Jr., Thomas, Compositions and methods of using (R)-pramipexole.
  26. Bozik, Michael E.; Petzinger, Jr., Thomas; Gribkoff, Valentin, Compositions and methods of using (R)-pramipexole.
  27. Norton, Richard L.; Zhou, Mingxing, Compositions comprising buprenorphine.
  28. Mash, Deborah C.; Gless, Jr., Richard D., Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier.
  29. Mash, Deborah C.; Gless, Richard D., Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier.
  30. Mash, Deborah C.; Moriarty, Robert M., Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier.
  31. Drust Eugene G. (Norwich NY) Kasting Gerald B. (Wyoming OH) Smith Ronald L. (West Chester OH) Szkutak Joan B. (West Chester OH), Compositions for the transdermal delivery of pharmaceutical actives.
  32. Bozik, Michael E.; Petzinger, Jr., Thomas; Gribkoff, Valentin, Compositions of R(+) and S(−) pramipexole and methods of using the same.
  33. Bozik, Michael E.; Petzinger, Jr., Thomas; Gribkoff, Valentin, Compositions of R(+) and S(−) pramipexole and methods of using the same.
  34. Oshlack, Benjamin; Wright, Curtis, Controlled-release compositions containing opioid agonist and antagonist.
  35. Cleary Gary W. (San Mateo CA), Diffusion matrix for transdermal drug administration and transdermal drug delivery devices including same.
  36. Kim Benjamin K. (Toms River NJ), Estradiol transdermal delivery system.
  37. Williams, Simon F., Flushable disposable polymeric products.
  38. Gale, Robert M.; Nelson, Melinda K.; Cormier, Michel J. N.; Gupta, Suneel K.; Campbell, Patricia S., Formulations for the administration of fluoxetine.
  39. Gale,Robert M.; Nelson,Melinda K.; Cormier,Michel J. N.; Gupta,Suneel K.; Campbell,Patricia S., Formulations for the administration of fluoxetine.
  40. van Osdol, William W.; Crisologo, Nieves M.; Yum, Su Il, Formulations for the transdermal administration of fenoldopam.
  41. van Osdol, William W.; Crisologo, Nieves M.; Yum, Su Il, Formulations for the transdermal administration of fenoldopam.
  42. Yum Su I ; Nelson Melinda K. ; Campbell Patricia S., Formulations for transdermal delivery of pergolide.
  43. Yum, Su Il; Nelson, Melinda K.; Campbell, Patricia S., Formulations for transdermal delivery of pergolide.
  44. Moriarty, Robert M.; Kinch, Mark, Halogenated indole and benzofuran derivatives of isoquinuclidene and processes for preparing them.
  45. Danagher, Helen Kathleen; Hayes, Geoffrey Gerard; Heun, Gerhard Josef; Mohammad, Hassan; Walden, Malcolm; Whitehouse, Jonathon Oliver, Immediate release pharmaceutical compositions comprising oxycodone and naloxone.
  46. Danagher, Helen Kathleen; Hayes, Geoffrey Gerard; Heun, Gerhard Josef; Mohammad, Hassan; Walden, Malcolm; Whitehouse, Jonathon Oliver, Immediate release pharmaceutical compositions comprising oxycodone and naloxone.
  47. Landrau Felix A. ; Nedberge Diane E. ; Hearney Linda Mary, Incorporating poly-N-vinyl amide in a transdermal system.
  48. Moriarty, Robert M., Indole and benzofuran fused isoquinuclidene derivatives and processes for preparing them.
  49. Norton, Richard L.; Watkins, Andrew; Zhou, Mingxing, Injectable flowable composition comprising buprenorphine.
  50. Brögmann, Bianca; Muhlau, Silke; Spitzley, Christof, Matrix for sustained, invariant and independent release of active compounds.
  51. Brögmann, Bianca; Mühlah, Silke; Spitzley, Christof, Matrix for sustained, invariant and independent release of active compounds.
  52. Brögmann, Bianca; Mühlau, Silke; Spitzley, Christof, Matrix for sustained, invariant and independent release of active compounds.
  53. Hyatt Gary F. ; Bostic William M., Medical applicator and method.
  54. Williams, Simon F.; Martin, David P.; Skraly, Frank A., Medical devices and applications of polyhydroxyalkanoate polymers.
  55. Rizk, Said; Martin, David P.; Ho, Kicherl; Williams, Simon F., Medical devices containing oriented films of poly-4-hydroxybutyrate and copolymers.
  56. Leyendecker, Petra; Hopp, Michael; Drews, Axel, Method and device for the assessment of bowel function.
  57. Harish Makker ; Shih-Liang S. Yang ; Daniel G. Brady ; Robert E. Glick, Method for making and using IOL insertion apparatus.
  58. Bernstein, Richard K., Method for reducing food intake.
  59. Cormier Michel J. N. (Palo Alto CA) Ledger Philip W. (Mountain View CA) Amkraut Alfred (Palo Alto CA) Marty Jean P. (Sceaux FRX), Method for reducing sensitization or irritation in transdermal drug delivery and means therefor.
  60. Osborne James L. (2365 Thompson Ct. Mountain View CA 94043) Nelson Melinda K. (1127 Hollenbeck Sunnyvale CA 94087) Enscore David J. (18291 Montpere Way Saratoga CA 95070) Yum Su I. (1021 Runnymead Ct, Method of administering nicotine transdermally.
  61. Bays F. Barry, Method of controlling post-operative leakage associated with tumescent liposuction.
  62. Martin, David P.; Rizk, Said; Ahuja, Ajay; Williams, Simon F., Method of making a medical textile from polyhydroxyalkanoate fibers.
  63. Rizk, Said, Method of making a polyhydroxyalkanoate filament.
  64. Palermo Philip J. ; Colucci Robert D. ; Kaiko Robert F., Method of preventing abuse of opioid dosage forms.
  65. Palermo, Philip J.; Kaiko, Robert F.; Colucci, Robert D., Method of preventing abuse of opioid dosage forms.
  66. Leeson Lewis J. (Roseland NJ), Method of treating memory impairment.
  67. Levine, Jon D., Method of treating pain using nalbuphine and opioid antagonists.
  68. Mash, Deborah C.; Gless, Jr., Richard D., Methods and compositions for preparing and purifying noribogaine.
  69. Mash, Deborah C.; Gless, Jr., Richard D., Methods and compositions for preparing and purifying noribogaine.
  70. Mash, Deborah C.; Moriarty, Robert M.; Gless, Jr., Richard D., Methods and compositions for preparing noribogaine from voacangine.
  71. Mash, Deborah C.; Moriarty, Robert M.; Gless, Jr., Richard D., Methods and compositions for preparing noribogaine from voacangine.
  72. Simon David Lew, Methods for improved regulation of endogenous dopamine in prolonged treatment of opioid addicted individuals.
  73. Ganatra, Amit; Felix, Fabio; Shah, Bhavin; Bernasconi, Matthew; Rizk, Said; Martin, David P.; Williams, Simon F., Methods of orienting multifilament yarn and monofilaments of poly-4-hydroxybutyrate and copolymers thereof.
  74. Ganatra, Amit; Felix, Fabio; Shah, Bhavin; Bernasconi, Matthew; Rizk, Said; Martin, David P.; Williams, Simon F., Methods of orienting multifilament yarn and monofilaments of poly-4-hydroxybutyrate and copolymers thereof.
  75. Bozik, Michael E.; Petzinger, Jr., Thomas; Gribkoff, Valentin, Modified release formulations of (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine and methods of using the same.
  76. Lee Eun Soo ; Watanabe Tyler ; Gale Robert M. ; Burkoth Terry L., Monoglyceride/lactate ester permeation enhancer for oxybutnin.
  77. Lee Eun Soo ; Watanabe Tyler ; Gale Robert M. ; Burkoth Terry L., Monoglyceride/lactate ester permeation enhancer for oxybutynin.
  78. Mash, Deborah C., N-substituted noribogaine prodrugs.
  79. Mash, Deborah C., N-substituted noribogaine prodrugs.
  80. Moriarty, Robert M.; Mash, Deborah C., Noribogaine compositions.
  81. Mash, Deborah C., Noribogaine in the treatment of pain and drug addiction.
  82. Mash, Deborah C., Noribogaine in the treatment of pain and drug addiction.
  83. Breder, Christopher; Wright, Curtis; Oshlack, Benjamin, Opiod agonist formulations with releasable and sequestered antagonist.
  84. Kaiko,Robert F.; Colucci,Robert D., Opioid agonist / antagonist combinations.
  85. Breder, Christopher; Wright, Curtis; Oshlack, Benjamin, Opioid agonist formulations with releasable and sequestered antagonist.
  86. Breder, Christopher; Wright, Curtis; Oshlack, Benjamin, Opioid agonist formulations with releasable and sequestered antagonist.
  87. Breder, Christopher; Wright, Curtis; Oshlack, Benjamin, Opioid agonist formulations with releasable and sequestered antagonist.
  88. Kaiko Robert F. ; Colucci Robert D., Opioid agonist/antagonist combinations.
  89. Kaiko, Robert F.; Colucci, Robert D., Opioid agonist/antagonist combinations.
  90. Kaiko, Robert F.; Colucci, Robert D., Opioid agonist/antagonist combinations.
  91. Kaiko, Robert F.; Colucci, Robert D., Opioid agonist/antagonist combinations.
  92. Kaiko, Robert F.; Colucci, Robert D., Opioid agonist/antagonist combinations.
  93. Kaiko, Robert F.; Colucci, Robert D., Opioid agonist/antagonist combinations.
  94. Kaiko, Robert F.; Colucci, Robert D., Opioid agonist/antagonist combinations.
  95. Kaiko,Robert F.; Colucci,Robert D., Opioid agonist/antagonist combinations.
  96. Robert F. Kaiko ; Robert D. Colucci, Opioid agonist/antagonist combinations.
  97. Kaiko, Robert F.; Colucci, Robert D., Opioid agonist/opioid antagonist/acetaminophen combinations.
  98. Kaiko, Robert F.; Colucci, Robert D., Opioid agonist/opioid antagonist/acetaminophen combinations.
  99. Kaiko, Robert F.; Colucci, Robert D., Opioid agonist/opioid antagonist/acetaminophen combinations.
  100. Robert F. Kaiko ; Robert D. Colucci, Opioid agonist/opioid antagonist/acetaminophen combinations.
  101. Fleischer, Wolfgang; Reimer, Karen; Leyendecker, Petra, Opioids for the treatment of the chronic obstructive pulmonary disease (COPD).
  102. Wright, IV, Curtis; Carpanzano, Anthony E., Oral dosage form comprising a therapeutic agent and an adverse-effect agent.
  103. Wright, IV,Curtis; Carpanzano,Anthony E., Oral dosage form comprising a therapeutic agent and an adverse-effect agent.
  104. Liang, Alfred; Matthews, Frank; Boehm, Garth; Tang, Lijuan; Johnson, Frank; Stauffer, Joseph, Pharmaceutical composition.
  105. Matthews, Frank; Boehm, Garth; Tang, Lijuan; Liang, Alfred, Pharmaceutical composition.
  106. Matthews, Frank; Boehm, Garth; Tang, Lijuan; Liang, Alfred, Pharmaceutical compositions.
  107. Matthews, Frank; Boehm, Garth; Tang, Lijuan; Liang, Alfred, Pharmaceutical compositions for the deterrence and/or prevention of abuse.
  108. Brögmann, Bianca; Mühlau, Silke; Spitzley, Christof, Pharmaceutical preparation containing oxycodone and naloxone.
  109. Brögmann, Bianca; Mühlau, Silke; Spitzley, Christof, Pharmaceutical preparation containing oxycodone and naloxone.
  110. Oshlack, Benjamin; Van Buskirk, Glenn; Chasin, Mark; Huang, Hua-Pin; Vashi, Vijay, Pharmaceutical product comprising a sequestered agent.
  111. Oshlack, Benjamin; Van Buskirk, Glenn; Chasin, Mark; Huang, Hua-Pin; Vashi, Vijay, Pharmaceutical products.
  112. Gless, Jr., Richard D.; Moriarty, Robert M., Phosphate esters of noribogaine.
  113. Martin, David P.; Rizk, Said; Ahuja, Ajay; Williams, Simon F., Polyhydroxyalkanoate medical textiles and fibers.
  114. Martin, David P.; Rizk, Said; Ahuja, Ajay; Williams, Simon F., Polyhydroxyalkanoate medical textiles and fibers.
  115. Martin, David P.; Rizk, Said; Ahuja, Ajay; Williams, Simon F., Polyhydroxyalkanoate medical textiles and fibers.
  116. Martin, David P.; Rizk, Said; Ahuja, Ajay; Williams, Simon F., Polyhydroxyalkanoate medical textiles and fibers.
  117. Wang Karly S. (Newark CA) Osborne James L. (Mountain View CA) Hunt James A. (Fremont CA) Nelson Melinda K. (Sunnyvale CA), Polyisobutylene adhesives for transdermal devices.
  118. Amkraut Alfred (Palo Alto CA) Shaw Jane E. (Atherton CA), Prevention of contact allergy by coadministration of a corticosteroid with a sensitizing drug.
  119. Seth Pawan (Oberwil CHX), Process for the production of an adhesive plaster.
  120. Martin, David P.; Rizk, Said; Ahuja, Ajay; Williams, Simon F., Process of making polyhydroxyalkanoate medical textiles.
  121. Cormier Michel J. N. ; Daddona Peter E. ; Johnson Juanita A., Reduction of skin reactions caused by transdermal drug delivery.
  122. Breder, Christopher; Oshlack, Benjamin; Wright, Curtis, Sequestered antagonist formulations.
  123. Breder, Christopher; Oshlack, Benjamin; Wright, Curtis, Sequestered antagonist formulations.
  124. Boehm, Garth, Sequestering subunit and related compositions and methods.
  125. Boehm, Garth, Sequestering subunit and related compositions and methods.
  126. Osborne James L. (Mountain View CA) Nelson Melinda (Sunnyvale CA) Enscore David J. (Saratoga CA) Yum Su I. (Los Altos CA) Gale Robert M. (Los Altos CA), Subsaturated nicotine transdermal therapeutic system.
  127. Osborne James L. ; Nelson Melinda ; Enscore David J. ; Yum Su Il ; Gale Robert M., Subsaturated nicotine transdermal therapeutic system.
  128. Enscore David J. (Sunnyvale CA) Campbell Patricia S. (Palo Alto CA) Osborne James L. (Mountain View CA) Smart Melinda K. (Sunnyvale CA) Yum Su I. (Los Altos CA), Subsaturated transdermal therapeutic system having improved release characteristics.
  129. Mash, Deborah C.; Gless, Jr., Richard D.; Moriarty, Robert M., Substituted noribogaine.
  130. Mash, Deborah C.; Gless, Jr., Richard D.; Moriarty, Robert M., Substituted noribogaine.
  131. Mash, Deborah C.; Gless, Jr., Richard D.; Moriarty, Robert M., Substituted noribogaine.
  132. Mash, Deborah C.; Gless, Richard D.; Moriarty, Robert M., Substituted noribogaine.
  133. Dadey, Eric; Li, Qi; Lindemann, Christopher, Sustained delivery formulations of risperidone compounds.
  134. Luk, Andrew S.; Junnarkar, Gunjan H.; Chen, Guohua, Sustained release small molecule drug formulation.
  135. Zhou, Mingxing; Norton, Richard L., Sustained-release buprenorphine solutions.
  136. Chen, Weirong; Humora, Michael; Kwok, Daw-Iong Albert; Kiesman, William F.; Irdam, Erwin Ayandra, Synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compounds.
  137. Chen, Weirong; Humora, Michael; Kwok, Daw-long Albert; Kiesman, William F.; Irdam, Erwin Ayandra, Synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compounds.
  138. Raje, Prasad; Gadikota, Rajendrakumar Reddy; Chen, Jian-Xie; Lapina, Olga V.; McCall, John M., Synthesis of chirally purified substituted benzothiazole diamines.
  139. Raje, Prasad; Gadikota, Rajendrakumar Reddy; Chen, Jian-Xie; Lapina, Olga V.; McCall, John M., Synthesis of chirally purified substituted benzothiazole diamines.
  140. Moriarty, Robert M.; Gless, Jr., Richard D., Synthetic noribogaine.
  141. Moriarty, Robert M., Synthetic voacangine.
  142. Moriarty, Robert M., Synthetic voacangine.
  143. Oshlack, Benjamin; Wright, Curtis; Haddox, J. David, Tamper resistant oral opioid agonist formulations.
  144. Howard, Stephen A.; Reidenberg, Bruce, Tamper resistant transdermal dosage form.
  145. Howard, Stephen A.; Reidenberg, Bruce, Tamper resistant transdermal dosage form.
  146. Oshlack, Benjamin; Wright, Curtis; Haddox, J. David, Tamper-resistant oral opioid agonist formulations.
  147. Oshlack, Benjamin; Wright, Curtis; Haddox, J. David, Tamper-resistant oral opioid agonist formulations.
  148. Oshlack, Benjamin; Wright, Curtis; Haddox, J. David, Tamper-resistant oral opioid agonist formulations.
  149. Oshlack, Benjamin; Wright, Curtis; Haddox, J. David, Tamper-resistant oral opioid agonist formulations.
  150. Oshlack, Benjamin; Wright, Curtis; Haddox, J. David, Tamper-resistant oral opioid agonist formulations.
  151. Oshlack, Benjamin; Wright, Curtis; Haddox, J. David, Tamper-resistant oral opioid agonist formulations.
  152. Oshlack, Benjamin; Wright, Curtis; Haddox, J. David, Tamper-resistant oral opioid agonist formulations.
  153. Oshlack, Benjamin; Wright, Curtis; Haddox, J. David, Tamper-resistant oral opioid agonist formulations.
  154. Oshlack, Benjamin; Wright, Curtis; Haddox, J. David, Tamper-resistant oral opioid agonist formulations.
  155. Oshlack, Benjamin; Wright, Curtis; Haddox, J.David, Tamper-resistant oral opioid agonist formulations.
  156. Oshlack, Benjamin; Wright, Curtis; Haddox, J.David, Tamper-resistant oral opioid agonist formulations.
  157. Oshlack, Benjamin; Wright, Curtis; Haddox, J.David, Tamper-resistant oral opioid agonist formulations.
  158. Stinchcomb, Audra L.; Swaan, Peter W., Transdermal delivery of opioid antagonist prodrugs.
  159. Shipman ; Jr. Charles (Dexter MI) Nassiri Mohammad R. (Ann Arbor MI) Flynn Gordon L. (Ann Arbor MI), Transdermal delivery of the narcotic analgesics etorphine and analogs.
  160. Yum, Su Il; Theeuwes, Felix, Transdermal delivery system for sufentanil.
  161. Yum, Su Il; Theeuwes, Felix, Transdermal delivery system for sufentanil.
  162. Yum, Su Il; Theeuwes, Felix, Transdermal delivery systems.
  163. Lee,Eun Soo; Yum,Su Il, Transdermal drug delivery device.
  164. Chang Yunik (Toms River NJ), Transdermal drug delivery using a dual permeation enhancer and method of performing the same.
  165. Gale, Robert M., Transparent transdermal nicotine delivery devices.
  166. Gale, Robert M., Transparent transdermal nicotine delivery devices.
  167. Gale, Robert M., Transparent transdermal nicotine delivery devices.
  168. Gale, Robert M., Transparent transdermal nicotine delivery devices.
  169. Gale, Robert M., Transparent transdermal nicotine delivery devices.
  170. Ebert, Charles D.; Sanders, Steven W., Unoccluded topical oxybutynin gel composition and methods for transdermal oxybutynin therapy.
  171. Bond, Richard A.; Glass, Mitchell, Use of beta-adrenergic inverse agonists for smoking cessation.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로